PFE
Pfizer Inc.
Pfizer Inc. is a global pharmaceutical company with significant federal contract exposure ($33.0B in obligations) and direct executive branch holdings by Donald J. Trump.
Govt Dependence
65/100
Regulatory Density
85/100
Lobbying Intensity
0/100
Political Signal
NEUTRAL
BusinessWhat PFE does
Pfizer Inc. develops, manufactures, and markets prescription medicines and vaccines globally. Its revenue lines include a substantial portfolio of patented drugs, biologics, and vaccines, with significant sales to U.S. government agencies. The company's business model is heavily reliant on intellectual property protection and regulatory approvals for new products.
12 months past · 3 months futurePFE activity timeline
Congress
buy
sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened
+ added
− trimmed
closed
holds
Bills
past action (this ticker)
upcoming markup (sector)
★ carveout (this ticker)
249 trading days ·
19 congressional trades shown
·
0 insider buys
·
9 13F filings
·
1 past bill actions
·
2 upcoming markups
Executive Branch ConflictsPFE held by Trump-administration officials
1 cabinet/senior official reported PFE positions in OGE Form 278 disclosures across 35 filings.
Donald J. Trump
President · White House
PFIZER INC
Donald J. Trump
President · White House
PFIZER INC
Donald J. Trump
President · White House
PFIZER INC
Donald J. Trump
President · White House
PFIZER INC
Donald J. Trump
President · White House
PFIZER INC
Donald J. Trump
President · White House
PFIZER INC
Donald J. Trump
President · White House
PFIZER INC
Donald J. Trump
President · White House
PFIZER INC
Donald J. Trump
President · White House
PFIZER INC
Donald J. Trump
President · White House
PFIZER INC
Donald J. Trump
President · White House
PFIZER INC
Donald J. Trump
President · White House
Pfizer Inc
pharma
Lifetime Government AwardsPFE federal contracts by year
$8.30B
total awarded · 2005–2020
1000
contracts on file
2010
peak year ($1217M)
Top contracts by award amount
$1216.9M
Department of Health and Human Serv
2010-04-01
TAS::75 0512::TAS 00HCVGBC-2010-82344 - WYETH PEDIATRIC VACCINE CONTRA
$1040.4M
Department of Health and Human Serv
2011-04-01
VACCINE FOR CHILDREN 2011
$1033.1M
Department of Health and Human Serv
2014-04-01
VACCINE FOR CHILDREN (VFC) 2014
$1029.0M
Department of Health and Human Serv
2017-04-01
IGF::OT::IGF 2017 VACCINES FOR CHILDREN
$976.9M
Department of Health and Human Serv
2012-04-01
VFC 2012
16 years · 1000 contracts
Smart Money · 13F HoldingsHedge funds holding PFE
$11.58B
Total PFE held by tracked 13F funds
4
Funds with PFE positions
Two Sigma Investments
$10.92B
-81%
6 overlap
2026-03-31
Citadel Advisors
$470M
+30%
6 overlap
2025-12-31
D.E. Shaw & Co.
$139M
+6%
6 overlap
2025-12-31
Millennium Management
$48M
holds
2025-12-31
Politicians Trading PFEMembers of Congress with recent PFE positions
18 politicians traded PFE across 88 disclosed transactions totaling $1.5M (last 730 days).
Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just PFE). 0-30 LOW · 30-60 MID · 60+ HIGH.
Ro Khanna
19 buys
11 sells
$436K
2026-04-13
LOW · 0
Robert P. Bresnahan
4 buys
2 sells
$195K
2025-05-15
LOW · 0
Gilbert Ray Cisneros
8 buys
8 sells
$177K
2026-03-13
HIGH · 61
J. French Hill
1 sell
$175K
2025-12-31
LOW · 1
Jefferson Shreve
2 buys
2 sells
$130K
2025-04-11
LOW · 0
Scott Franklin
4 sells
$81K
2024-08-06
LOW · 0
Laurel M. Lee
2 buys
$65K
2024-10-21
LOW · 0
Susan M. Collins
1 buy
$33K
2026-02-03
LOW · 0
Tommy Tuberville
1 sell
$33K
2026-06-08
LOW · 8
Bruce Westerman
2 buys
2 sells
$32K
2025-04-21
LOW · 0
Julie Johnson
4 sells
$32K
2025-02-12
LOW · 15
Lisa C. McClain
2 buys
2 sells
$32K
2025-08-04
LOW · 0
John Boozman
2 sells
$16K
2025-02-13
MID · 47
Josh Gottheimer
2 sells
$16K
2025-06-03
LOW · 1
Greg Landsman
2 sells
$16K
2024-10-15
LOW · 0
3 more politicians active in PFE · full table in member dashboard
Congressional TradesWho in Congress is trading PFE
2026-06-08
Tommy Tuberville
Sale
$15,001 - $50,000
2026-04-13
Ro Khanna
Purchase
$1,001 - $15,000
2026-03-13
Gilbert Ray Cisneros
Sale
$1,001 - $15,000
2026-02-03
Susan M. Collins
Purchase
$15,001 - $50,000
2026-02-10
Gilbert Ray Cisneros
Purchase
$1,001 - $15,000
2026-01-22
Ro Khanna
Sale
$1,001 - $15,000
2025-12-31
J. French Hill
Sale
$100,001 - $250,000
2025-06-17
Julia Letlow
Purchase
$1,001 - $15,000
210d late
2025-12-19
Gilbert Ray Cisneros
Sale
$1,001 - $15,000
2025-11-18
Gilbert Ray Cisneros
Purchase
$1,001 - $15,000
2025-09-15
Ro Khanna
Sale
$1,001 - $15,000
2025-09-05
Ro Khanna
Sale
$1,001 - $15,000
30+ trades on file · most recent 2026-07-16
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
Stock awards & option exercises
25
stock awards · $66.1M market value
12
option exercises · $53.0M
2026-04-15
BOURLA ALBERT
Chairman & CEO
AWARD
22 sh
$598
2026-04-14
BOURLA ALBERT
Chairman & CEO
AWARD
911 sh
$25K
2026-03-31
BOURLA ALBERT
Chairman & CEO
AWARD
21 sh
$590
2026-03-27
NARAYEN SHANTANU
Director
AWARD
1,849.112 sh
$50K
2026-03-27
Echevarria Joseph
Director
AWARD
1,710.429 sh
$46K
2026-03-27
SMITH JAMES C
Director
AWARD
1,664.201 sh
$45K
2026-03-27
Quincey James
Director
AWARD
1,433.062 sh
$39K
2026-03-27
Buckley Mortimer J
Director
AWARD
1,386.834 sh
$38K
For PFE, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.
Bills Affecting PFELive legislation impacting this stock
S.9 · 119th
Protection of Women and Girls in Sports Act of 2025
S.1387 · 119th
National Biotechnology Initiative Act of 2025
HR.2756 · 119th
National Biotechnology Initiative Act of 2025
S.1302 · 119th
Increasing Transparency in Generic Drug Applications Act
HR.1843 · 119th
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
HR.1492 · 119th
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates und
HR.1060 · 119th
Modern Authentication of Pharmaceuticals Act of 2025
HR.843 · 119th
Prompt Approval of Safe Generic Drugs Act
HR.297 · 119th
HELP PETS Act
S.63 · 119th
CBW Fentanyl Act
Political ProfileWhere PFE sits in Washington
[object Object]
STRUCTURAL: High federal contract concentration ($33.0B) and executive branch holding (Trump). EVIDENTIARY: No recent corporate insider cluster buys (tier F, 0 buys in 180 days per `get_corporate_insider_signal`), but active congressional trading (16 trades by 5 members in 12 months). Net: Strong structural ties offset by neutral evidentiary signals.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Potential drug pricing legislationCongress"Eight recent bills with pharma sector impact_ratios of 0.0001 per `bill_impacts` array."
Regulatory opportunities
-
Continued federal procurement for vaccines and medicinesDepartment of Health and Human Services"478 federal contracts totaling $33.0B in obligations across four agencies per `get_government_precedent.federal_contracts_summary[0]`."
Capitol Hill AlliesChampions & critics
Congressional champions
Congressional critics
- No specific congressional critics identified.
Member intelligence layer
Live signals + predictions for PFE — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades PFE
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord
Frequently AskedAbout PFE & political exposure
Does Pfizer Inc. (PFE) hold federal contracts?
Yes. Pfizer Inc. has 5179 federal contract awards totaling $40,166,734,342, primarily from agencies including Agency for International Development, Department of Agriculture, Department of Defense. See full contract list and amounts on this page.
Which Trump cabinet officials own PFE stock?
1 Trump cabinet members or senior White House staff have disclosed holdings in PFE on their OGE 278 financial disclosures, including Donald J. Trump. See the Cabinet Conflicts panel for details.
Has Congress traded PFE stock?
766 congressional trades by 69 unique members of Congress, most recently on 2026-06-08. See the Congressional Trading panel for politician-by-politician breakdown.
What is PFE political risk profile?
Government dependence: 65/100. Lobbying intensity: 0/100. Political signal: neutral. Donor party split: R 50% / D 50%.
How does GovGreed track PFE political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. PFE data is updated daily from these official federal sources.